Naloxone, known by brand names Nyxoid or Narcan, rapidly reverses the depression of the central nervous and respiratory systems caused by opioids.
Articles on opioid misuse
Displaying all articles
A fentanyl vaccine is going to human clinical trials after showing promising results in rats – but here’s why it’s no cure-all for the opioid crisis.
Long-acting injectable buprenorphine is also known by the brand names Buvidal or Sublocade.
A one-dimensional approach to reducing opioid use isn’t favoured by health care professionals or patients.
A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.
Top contributors
-
Professor of Criminology, University of South Wales
-
Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire
-
Research Associate, Curtin University
-
Associate professor, Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney
-
Professor, Institute for Musculoskeletal Health, University of Sydney
-
Professor, National Drug Research Institute, Curtin University
-
Pharmacist, Lecturer, NHMRC Emerging Leadership Fellow, Sydney Pharmacy School, The University of Sydney, University of Sydney
-
Deputy Director, SA Centre for Economic Studies, Adelaide University
-
Associate Professor, School of Pharmacy, Faculty of Medicine and Health, University of Sydney, University of Sydney
-
Senior Research Fellow, National Drug Research Institute, Curtin University
-
Professor of Neuropharmacology, University of Lancashire
-
Professor at the National Drug & Alcohol Research Centre, UNSW